Keeping in line with ‘Make in India’ scheme, Chennai-based healthcare Startup vTitan has announced the launch of syringe infusion pumps—a next-generation medical devices—used for critical care administration in hospitals and home environments for accurate and safe infusion of medication.
In its first phase of launch, the company has introduced Accuflow SP-550 and Accuflow IBP-550 Syringe Infusion Pumps powered by indigenously developed and patented closed-loop motion control technology.
These pumps are capable of supplying fluids such as insulin, antibiotics, chemotherapy drugs, pain relievers, etc.
“We aim to create and build quality medical products in India for the global healthcare industry. Our major goal is to make medical device technology and product solutions available, accessible and affordable for all,” Peri Kasthuri, Co-founder and CEO of vTitan Corporation said.
“We are committed to Make in India products for global healthcare industry. To strengthen the same, we are investing in building the R&D team, with strong emphasis on innovation and creativity,” he added.
In order to manufacture products in India, vTitan is also training graduates while enhancing their skills in the said field. The move seen to boost the manufacture ecosystem in India.
The company aims to become a 50 crore company by FY 2022. It also intends to expand pan-India by 2018 year-end, and further venture into West Asia and Africa by 2019, the official statement said.